Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allakos, Anaptysbio, Astrazeneca, Biovaxys, Cohbar, Collegium, Contrafect, Cytodyn, Geovax, GSK, Lidds, Moderna, Novartis, Olema, Quell, Resverlogix, Revolution, TFF, Titan.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Advaxis, Allakos, Allergy, Amarin, Ana, Arcutis, Atyr, Biocardia, Biophytis, Biosig, Cingulate, Crinetics, Exelixis, Forma, Galera, Glycomimetics, Gmax, Hifibio, Kiniksa, Mustang, Nanobiotix, NBE, Novartis, PTC, Regeneron, Rexgenero, Sanofi, VBI.

Biopharmas raising money in public or private financings, including: Atea, Eternygen, Scorpion, SQZ, Sunshine, Turning Point.

New hires and promotions in the biopharma industry, including: Adaptate, Canbridge, Circle, Cogent, Cyclacel, Genprex, Nurix, Visus.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: GI Supply.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 1health.io, Arc Bio, Genesprint Group, Holo Surgical, IMEC, Infrawear, Remote Medical International, Royal Philips, Suralign Holdings, TÜV Rheinland.

Med-tech firms raising money in public or private financings, including: Eucrates Biomedical Acquisition, Vapotherm, Xtant Medical Holdings.

New hires and promotions in the med-tech industry, including: Avia, Zynex.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ascendis, Astrazeneca, Evgen, Kezar.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allarity, Astrazeneca, Bayer, BMS, Curevac, Entos, Gilead, Immunomedics, Innate, Innocan, KBP, Medicago, Nicox, Orphazyme, Precision Nanosystems.